Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 3, 2011, Pages 617-624

  Urner, Martin ^a,b   Limbach, Ludwig K ^c   Herrmann, Inge K ^c   Müller Edenborn, Björn ^a,b   Roth Z'Graggen, Birgit ^a,b   Schlicker, Andreas ^a,b   Reyes, Livia ^a,b   Booy, Christa ^a,b   Hasler, Melanie ^a   Stark, Wendelin J ^c   Beck Schimmer, Beatrice ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Endothelial cells; Epithelial cells; Halogenation; Lipopolysaccharides; Sevoflurane

Indexed keywords

CD11B ANTIGEN; DESFLURANE; ENDOTOXIN; ETHER; HALOTHANE; ISOFLURANE; L SELECTIN; LIPOPOLYSACCHARIDE; SEVOFLURANE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; FLUORINATION; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANESTHETICS; ANIMALS; AORTA; CARBON; CASPASE 3; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; EPITHELIAL CELLS; ESCHERICHIA COLI; FLUORINE; HALOGENS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; LIPOPOLYSACCHARIDES; METHYL ETHERS; MICROCIRCULATION; NEUTROPHILS; RATS;

EID: 80052526467     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0451OC     Document Type: Article

References (34)

1. Kitakaze M. How to mediate cardioprotection in ischemic hearts - Accumulated evidence of basic research should translate to clinical medicine. Cardiovasc Drugs Ther 2010;24:217-223.
2. Ross S., Foex P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999;82:622-632. (Pubitemid 29151249)
3. Voigtsberger S., Lachmann R.A., Leutert A.C., Schlapfer M., Booy C., Reyes L., Urner M., Schild J., Schimmer R.C., Beck-Schimmer B. Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury. Anesthesiology 2009;111:1238-1248.
4. Steurer M., Schlapfer M., Z'Graggen BR, Booy C, Reyes L, Spahn DR, Beck-Schimmer B. The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophages. Clin Exp Immunol 2009;155:224-230.
5. De Conno E., Steurer M.P., Wittlinger M., Zalunardo M.P., Weder W., Schneiter D., Schimmer R.C., Klaghofer R., Neff T.A., Schmid E.R., et al. Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology 2009;110:1316-1326.
6. Sharma A.K., Fernandez L.G., Awad A.S., Kron I.L., Laubach V.E. Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced tnf-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2007;293:L105-L113. (Pubitemid 47080718)
7. Beck-Schimmer B., Schimmer R.C., Pasch T. The airway compartment: Chambers of secrets. News Physiol Sci 2004;19:129-132.
8. Ware L.B., Koyama T., Billheimer D.D., Wu W., Bernard G.R., Thompson B.T., Brower R.G., Standiford T.J., Martin T.R., Matthay M.A. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010;137:288-296.
9. Schilling T., Kozian A., Kretzschmar M., Huth C., Welte T., Buhling F., Hedenstierna G., Hachenberg T. Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. Br J Anaesth 2007;99:368-375. (Pubitemid 47316390)
10. Guarracino F., Landoni G., Tritapepe L., Pompei F., Leoni A., Aletti G., Scandroglio A.M., Maselli D., De Luca M., Marchetti C., et al. Myocardial damage prevented by volatile anesthetics: A multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006;20:477-483. (Pubitemid 44119282)
11. Landoni G., Fochi O., Torri G. Cardiac protection by volatile anaesthetics: A review. Curr Vasc Pharmacol 2008;6:108-111.
12. Beck-Schimmer B., Breitenstein S., Urech S., De Conno E., Wittlinger M., Puhan M., Jochum W., Spahn D.R., Graf R., Clavien P.A. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008;248:909-918.
13. Zaugg M. Is protection by inhalation agents volatile? Controversies in cardioprotection. Br J Anaesth 2007;99:603-606. (Pubitemid 351773227)
14. Lundien M.C., Mohammed K.A., Nasreen N., Tepper R.S., Hardwick J.A., Sanders K.L., Van Horn R.D., Antony V.B. Induction of MCP-1 expression in airway epithelial cells: Role of CCR2 receptor in airway epithelial injury. J Clin Immunol 2002;22:144-152. (Pubitemid 34596938)
15. Ritter C., Da Cunha A.A., Echer I.C., Andrades M., Reinke A., Lucchiari N., Rocha J., Streck E.L., Menna-Barreto S., Moreira J.C., et al. Effects of Nacetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 2006;34:471-477. (Pubitemid 43145628)
16. Beck-Schimmer B., Schwendener R., Pasch T., Reyes L., Booy C., Schimmer R.C. Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res 2005;6:14.
17. Madjdpour C., Oertli B., Ziegler U., Bonvini J.M., Pasch T., Beck-Schimmer B. Lipopolysaccharide induces functional ICAM-1 expression in rat alveolar epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000;278:L572-L579. (Pubitemid 30152515)
18. Yue T, Roth Z'graggen B, Blumenthal S, Neff SB, Reyes L, Booy C, Steurer M, Spahn DR, Neff TA, Schmid ER, et al. Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro. Eur Respir J 2008;31:118-125.
19. Z'Graggen BR, Tornic J, Muller-Edenborn B, Reyes L, Booy C, Beck-Schimmer B. Acute lung injury: Apoptosis in effector and target cells of the upper and lower airway compartment. Clin Exp Immunol 2010;161:324-331.
20. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-352. (Pubitemid 10115803)
21. Zaugg M., Jamali N.Z., Lucchinetti E., Shafiq S.A., Siddiqui M.A. Norepinephrine-induced apoptosis is inhibited in adult rat ventricular myocytes exposed to volatile anesthetics. Anesthesiology 2000;93:209-218. (Pubitemid 30436696)
22. Wise-Faberowski L., Raizada M.K., Sumners C. Oxygen and glucose deprivation-induced neuronal apoptosis is attenuated by halothane and isoflurane. Anesth Analg 2001;93:1281-1287. (Pubitemid 33021034)
23. Lucchinetti E., Ambrosio S., Aguirre J., Herrmann P., Harter L., Keel M., Meier T., Zaugg M. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007;106:262-268. (Pubitemid 46185170)
24. Fast J.P., Mecozzi S. Nanoemulsions for intravenous drug delivery. In de Villiers MM, Aramwit P, Kwon GS, editors. Biotechnology: pharmaceutical aspects: New York: Springer; 2009. pp. 461-489.
25. Kawamoto M., Suzuki N., Takasaki M. Acute pulmonary-edema after intravenous liquid halothane in dogs. Anesth Analg 1992;74:747-752.
26. Fast J.P., Perkins M.G., Pearce R.A., Mecozzi S. Fluoropolymer-based emulsions for the intravenous delivery of sevoflurane. Anesthesiology 2008;109:651-656.
27. Hoang K.C., Mecozzi S. Aqueous solubilization of highly fluorinated molecules by semifluorinated surfactants. Langmuir 2004;20:7347-7350.
28. Cascorbi H.F., Helrich M., Krantz J.C. Jr, Baker L.R., Rozman R.S., Rudo F.G. Hazards of methoxyflurane emulsions in man. Anesth Analg 1968;47:557-559.
29. Vanstee E.W. Toxicology of inhalation: Anesthetics and metabolites. Annu Rev Pharmacol Toxicol 1976;16:67-79.
30. Kharasch E.D., Karol M.D., Lanni C., Sawchuk R. Clinical sevoflurane metabolism and disposition. I: Sevoflurane and metabolite pharmacokinetics. Anesthesiology 1995;82:1369-1378.
31. Zagorski J., Gellar M.A., Obraztsova M., Kline J.A.,Watts J.A. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. J Immunol 2007;179:7820-7826.
32. Hayashidani S., Tsutsui H., Shiomi T., Ikeuchi M., Matsusaka H., Suematsu N., Wen J., Egashira K., Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003;108:2134-2140. (Pubitemid 37337591)
33. Souza D.G., Bertini R., Vieira A.T., Cunha F.Q., Poole S., Allegretti M., Colotta F., Teixeira M.M. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Br J Pharmacol 2004;143:132-142. (Pubitemid 39280032)
34. Miura M., Fu X., Zhang Q.W., Remick D.G., Fairchild R.L. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 2001;159:2137-2145. (Pubitemid 33104268)